hotspot -WSS

hotspot

author：comprehensive 2025-10-02 17:56:17 - browse：88585

STAT's Damian Garde speaks with Mikael Dolsten and Mathai Mammen, in New York on March 21, 2024 — From left to right, STAT's Damian Garde; Mikael Dolsten, chief scientific officer of Pfizer research and development; and Rose Loughlin, Moderna’s senior vice president of early research and development, discuss the future of pharma at the STAT 2024 Breakthrough Summit East. STAT

Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more nuanced interpretation of precision medicine, three biotech leaders said at the STAT Breakthrough Summit East in New York Thursday.

“We used to say, well, you may spend five years in the research phase, another five in development. Now I see a project that takes one year of research, from an idea to studies,” said Mikael Dolsten, chief scientific officer and president of Pfizer research and development. “Time is life. You care about patients. And when the distance to run is long, it holds back the energy and the inspiration.”

Key to that success are transformative new technologies like messenger RNA, which powered vaccines developed by Pfizer with its partner BioNTech.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

WSS

A rare thyroid diagnosis led to unexpected, all

How to protect patients from sexual assault

Medicaid rebukes states for mistakenly disenrolling children

Covid hospitalizations on the rise, Humana says

Reports of telehealth's death have been greatly exaggerated

AstraZeneca chief proposes a novel edit to the drug pricing bill

hotspot

hotspot

hotspot

Bright Health sells Medicare Advantage business to Molina

Reports of telehealth's death have been greatly exaggerated

In age of alternative facts, a scholarly course on calling out crap

Reports of telehealth's death have been greatly exaggerated

The high cost of giving birth even with insurance

NIH nominee Bertagnolli will get October confirmation hearing

Supreme Court strikes down use of affirmative action

House transparency, PBM reform bill gains bipartisan support

How one medical school became remarkably diverse

Crinetics acromegaly drug succeeds in late

leisure time

Cue Health, Covid

ALS advocates say criticism of new drugs misses bigger picture

UnitedHealth argues against case alleging wrongful AI care denials

Advances in CAR

The (many) problems with a new study criticizing cancer screening

Crinetics acromegaly drug succeeds in late

leisure time

knowledge

hotspot

explore